Phoebe Lee - Orient Europharma Chief Officer
| 4120 Stock | TWD 48.10 0.30 0.63% |
Insider
Phoebe Lee is Chief Officer of Orient Europharma Co
| Phone | 886 2 2755 4881 |
| Web | https://www.oepgroup.com |
Orient Europharma Management Efficiency
Orient Europharma's management efficiency ratios could be used to measure how well Orient Europharma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| YenWei Ding | International CSRC Investment | N/A | |
| KuoHong Yeh | International CSRC Investment | N/A | |
| DongSiang Lu | PChome Online | N/A | |
| LiWen Tsai | International CSRC Investment | N/A | |
| ShuHui Yang | Chung Hwa Food | N/A | |
| IChen Tsai | International CSRC Investment | N/A | |
| KungKai Koo | International CSRC Investment | N/A | |
| Fu Chen | International CSRC Investment | N/A | |
| TienFu Chao | International CSRC Investment | N/A | |
| PoSung Huang | International CSRC Investment | N/A | |
| ChaoPin Chang | Sporton International | N/A | |
| YuShu Hu | PChome Online | N/A | |
| MingChih Huang | Sporton International | N/A | |
| Xiong Peng | International CSRC Investment | N/A | |
| WeiShen Hung | International CSRC Investment | N/A | |
| ChienNan Tsao | Formosa International Hotels | N/A | |
| KungYi Koo | International CSRC Investment | N/A | |
| ChiaWen Lee | International CSRC Investment | N/A | |
| Lei Chou | PChome Online | N/A | |
| YuJuan Jian | Chung Hwa Food | N/A | |
| Xun Tseng | PChome Online | N/A | |
Management Performance
| Return On Equity | -0.0268 | |||
| Return On Asset | -0.0027 |
Orient Europharma Leadership Team
Elected by the shareholders, the Orient Europharma's board of directors comprises two types of representatives: Orient Europharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orient. The board's role is to monitor Orient Europharma's management team and ensure that shareholders' interests are well served. Orient Europharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orient Europharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Liann Lai, Director Division | ||
| Jack Wu, Director | ||
| Phoebe Lee, Chief Officer | ||
| Peter Tsai, CEO Chairman |
Orient Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orient Europharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0268 | |||
| Return On Asset | -0.0027 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 5.9 B | |||
| Shares Outstanding | 86.75 M | |||
| Shares Owned By Insiders | 65.10 % | |||
| Shares Owned By Institutions | 0.45 % | |||
| Price To Book | 1.07 X | |||
| Price To Sales | 0.68 X |
Pair Trading with Orient Europharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Orient Europharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Europharma will appreciate offsetting losses from the drop in the long position's value.Moving against Orient Stock
| 0.48 | 3711 | ASE Industrial Holding | PairCorr |
| 0.42 | 2330 | Taiwan Semiconductor | PairCorr |
| 0.33 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.32 | 0057 | Fubon MSCI Taiwan | PairCorr |
| 0.31 | 2609 | Yang Ming Marine | PairCorr |
The ability to find closely correlated positions to Orient Europharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Orient Europharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Orient Europharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Orient Europharma Co to buy it.
The correlation of Orient Europharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Orient Europharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Orient Europharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Orient Europharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Orient Stock Analysis
When running Orient Europharma's price analysis, check to measure Orient Europharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Europharma is operating at the current time. Most of Orient Europharma's value examination focuses on studying past and present price action to predict the probability of Orient Europharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Europharma's price. Additionally, you may evaluate how the addition of Orient Europharma to your portfolios can decrease your overall portfolio volatility.